US Patent Issued to Gmax Biopharm on April 7 for "ET a R antibody, and pharmaceutical compositions and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,334, issued on April 7, was assigned to Gmax Biopharm LLC (Hangzhou, China).

"ET a R antibody, and pharmaceutical compositions and use thereof" was invented by Cheng Zhang (Hangzhou, China), Kesuo Fan (Hangzhou, China), Yong Guo (Hangzhou, China), Chenjiang Yao (Hangzhou, China), Hua Zhang (Hangzhou, China), Xiaofeng Wang (Hangzhou, China) and Shuqian Jing (Hangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are a stable solution formulation of an ETAR antibody, and use thereof in treating, preventing, or alleviating one or more symptoms of pulmonary arterial hypertension or one or more symptoms of cancer of a reproductive...